Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

360 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 360 results

Early research (Phase 1)Study completedNCT05177640
What this trial is testing

Biodistribution and Dosimetry of 99mTc-Duramycin

Who this might be right for
Healthy Volunteers
University Hospital, Antwerp 6
Early research (Phase 1)WithdrawnNCT03241446
What this trial is testing

Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
Navidea Biopharmaceuticals
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06880757
What this trial is testing

177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Ankara University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Early research (Phase 1)Looking for participantsNCT07114601
What this trial is testing

LY4257496 in Participants With Cancer (OMNIRAY)

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more
Eli Lilly and Company 421
Not applicableStudy completedNCT03580161
What this trial is testing

Simplification of Low Level Internal Dosimetry

Who this might be right for
Exposure to Medical Diagnostic Radiation
Royal Marsden NHS Foundation Trust 12
Not applicableStudy completedNCT03665181
What this trial is testing

Crystalline Exposition During Pediatric Cranial CT Imaging

Who this might be right for
Any Pathology Requiring a Cranial CT Imaging
University Hospital, Bordeaux 23
Very early researchNot Yet RecruitingNCT07420036
What this trial is testing

An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors

Who this might be right for
Neoplasms
Zhongnan Hospital 98
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07249892
What this trial is testing

BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Who this might be right for
Metastatic Solid Tumors
Chengdu Syncor Pharmaceutical Co., Ltd. 195
Early research (Phase 1)Study completedNCT01738347
What this trial is testing

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Who this might be right for
Relapsing-remitting Multiple Sclerosis (rrMS)
GE Healthcare 30
Early research (Phase 1)Looking for participantsNCT07149831
What this trial is testing

A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults

Who this might be right for
Prostate Cancer
Sinotau Pharmaceutical Group 6
Not applicableStudy completedNCT03692104
What this trial is testing

US-CT Fusion for Post Implant Dosimetry

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 25
Testing effectiveness (Phase 2)Study completedNCT02162446
What this trial is testing

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 12
Very early researchNot Yet RecruitingNCT07542379
What this trial is testing

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd. 13
Post-approval studies (Phase 4)Study completedNCT00882596
What this trial is testing

Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients

Who this might be right for
Breast Cancer
Cancer Center of Irvine 30
Not applicableActive Not RecruitingNCT05743842
What this trial is testing

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 19
Not applicableUnknownNCT00749697
What this trial is testing

Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

Who this might be right for
Thyroid CarcinomaMetastatic Sites Lung Bone Nodal
Royal Marsden NHS Foundation Trust 10
Early research (Phase 1)Study completedNCT00426959
What this trial is testing

Study of Image-guided Dosimetry for Interstitial Prostate Brachytherapy

Who this might be right for
Locally Confined Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Early research (Phase 1)Study completedNCT03822871
What this trial is testing

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 17
Early research (Phase 1)UnknownNCT06237491
What this trial is testing

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
Yantai LNC Biotechnology Singapore PTE. LTD. 12
Load More Results